Pharma Stocks
-
Teva’s Turnaround Is Working. Here’s the 1 Thing That Could Send It Soaring Another 50%.
Year to date, Teva Pharmaceutical Industries (NYSE: TEVA) shares have continued to recover. Thanks to the company’s shifting focus from…
Read More » -
CSPC Pharmaceutical Group (SEHK:1093) Could Be 115% Below Fair Value Following Drug Approval
CSPC Pharmaceutical Group (SEHK:1093) has secured marketing approval in China for its once-monthly Paliperidone Palmitate Injection for schizophrenia, a development…
Read More » -
Israel “Izzy” Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn’t?
You don’t become one of the world’s wealthiest hedge fund managers by making ill-advised investing decisions. And make no mistake…
Read More » -
Israel “Izzy” Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn’t?
You don’t become one of the world’s wealthiest hedge fund managers by making ill-advised investing decisions. And make no mistake…
Read More » -
Pharma is the new tech; sector to remain a top bet despite potential US tariffs, says N Jayakumar
Pharmaceutical stocks remain one of the top investment bets despite concerns over potential US tariffs, according to N Jayakumar, Group…
Read More » -
Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative
In July 2026, Merck announced an early, multi-pronged access plan for its investigational once-monthly HIV PrEP pill alimatravir (MK-8527), including…
Read More » -
AbbVie (ABBV) Could Be 3% Undervalued Following Epcoritamab Trial Setback
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors…
Read More » -
Axsome Therapeutics (AXSM) Wins FDA NDA Acceptance, Is The Stock Fully Valued?
Why Axsome Therapeutics Stock Is Back in Focus After the Latest FDA Milestone Axsome Therapeutics (AXSM) is drawing fresh attention…
Read More » -
Amneal Pharmaceuticals (AMRX) Stock May Be Fully Priced Following Its 4.7x Run
Amneal Pharmaceuticals has turned in a very strong share price run over the last few years, yet its valuation checks…
Read More » -
How EMA’s Positive CHMP Opinion on Ubeslo and Evlarco at NewAmsterdam Pharma (NAMS) Has Changed Its Investment Story
NewAmsterdam Pharma Company N.V. and Menarini Group recently reported that the EMA’s CHMP issued a positive opinion recommending EU-wide marketing…
Read More »